News

EnChannel Medical, a breakthrough innovator in cardiac electrophysiology, today announced the successful completion of an oversubscribed Series B financing, raising $82.2M (600M RMB).

Groundbreaking device sets new standard in the management of patients with an elevated risk of sudden cardiac arrest

Catheter Precision, Inc., a US-based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market, announced that new clinical data about VIVO is available.

Milestone results formed the basis of HeartBeam’s 12-lead ECG synthesis software application submitted to FDA in January 2025

Huxley Medical unveiled promising investigational data from the company's SANSA monitoring platform at the Heart Rhythm Society meeting.

New data highlights strong wear compliance, meaningful arrhythmia detection, and continuity of care in community-based advanced practice provider-driven model

iRhythm Technologies, Inc. announced results from a large real-world retrospective analysis presented at the Heart Rhythm Society’s annual meeting, HRS2025.

Engineered using an acrylic formula infused with bismuth (Bi), a non-toxic and stable element, ClearShield panels are transparent, eco-conscious, and manufactured entirely in the United States.

This milestone partnership supports the mission of both organizations to improve clinical trials through advanced medical technology.

Late-breaking data from Abbott's groundbreaking first-in-human study demonstrated successful implantation of the company's AVEIR Conduction System Pacing (CSP) leadless pacemaker